Legend Biotech· @LegendBiotech · X·· 5 天前AI 评分42
AI 导读
#IMS2026 里程碑时刻：今天，Adam D. Cohen 医学博士公布了 CARTITUDE-2 A 队列的 5 年研究结果，为更早线治疗后 RRMM 患者的长期结局提供了新见解。 探索关键发现：https://bit.ly/4hM5WuA #LegendBiotech #MultipleMyeloma #CellTherapy #CART
正文
A milestone moment at #IMS2026: Today, Adam D. Cohen, MD, presented 5-year CARTITUDE-2 Cohort A findings, contributing new insights into long-term RRMM patient outcomes following earlier-line treatment.
Explore the key findings: https://bit.ly/4hM5WuA
#LegendBiotech #MultipleMyeloma #CellTherapy #CART
来源：Legend Biotech · x.com